Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China

BACKGROUND: To evaluate off-label and off-NCCN guidelines uses of antineoplastic drugs in a major Chinese hospital. METHODS: Totally 1122 patients were selected from July to December 2011. Then, the off-label and off-NCCN guidelines uses of antineoplastic drugs were analyzed. RESULTS: In 798 of 1122...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, Weilan, ZHU, Man, GUO, Daihong, CHEN, Chao, WANG, Dongxiao, PEI, Fei, MA, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684455/
https://www.ncbi.nlm.nih.gov/pubmed/23802104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684455/
https://www.ncbi.nlm.nih.gov/pubmed/23802104

Ejemplares similares